Search Results
|
Results for '' |
| Title | Publication Date | Price |
|---|---|---|
| Glucose Monitoring Devices Market Worldwide 2010 – 2014 |
July 2010 | £455 |
| Commercial Insight: Osteoporosis Market players maximize revenue growth before the next challenging phase |
July 2010 | £9835 |
| Human Embryonic Stem Cells A Global Market Overview |
July 2010 | £3030 |
| U.S. Inherited Disease Molecular Diagnostics Markets | July 2010 | £3880 |
| Alzheimer’s Disease Immunotherapy Pipeline Vaccines, Therapeutic Antibodies and Emerging Strategies |
July 2010 | £1500 |
| Commercial and Pipeline Insight: Insomnia Future of innovative orexin drug class in doubt |
July 2010 | £9835 |
| Pipeline Insight: Migraine Challenges ahead for first-in-class developments |
July 2010 | £9835 |
| Stakeholder Opinions: Ovarian Cancer Approaching the era of molecular targeted therapy |
July 2010 | £2460 |
| Stakeholder Insight: Multiple Sclerosis Next generation therapies signal the start of a new era |
July 2010 | £9835 |
| Chinese Markets for Cancer Treatment Drugs | July 2010 | £2590 |
| Chinese Markets for Pharmaceuticals | July 2010 | £2590 |
| Bristol-Myers Squibb Co.: PharmaVitae Profile | July 2010 | £3690 |
| Genzyme Corporation: PharmaVitae Profile | July 2010 | £3690 |
| Top 50 Pharmaceutical Companies Report | July 2010 | £820 |
| Lithuania Pharmaceuticals and Healthcare Report Q3 2010 |
July 2010 | £330 |
| Worldwide Heart Valve Market Report 2010 Edition |
July 2010 | £525 |
| Allergic Rhinitis Pipeline Assessment and Market Forecasts to 2017 |
July 2010 | £1295 |
| Chinese Markets for HIV Treatment Drugs | July 2010 | £2590 |
| Migraine Pipeline Assessment and Market Forecasts to 2016 |
July 2010 | £1295 |
| Idiopathic Pulmonary Fibrosis Pipeline Assessment and Market Forecasts to 2017 |
July 2010 | £1295 |
| India Pharmaceuticals and Healthcare Report Q3 2010 |
July 2010 | £330 |
| Chile Pharmaceuticals and Healthcare Report Q3 2010 |
July 2010 | £330 |
